Nitric oxide in the eye: Multifaceted roles and diverse outcomes

Survey of Ophthalmology

Volumn 42, Issue 1, 1997, Pages 71-82

  Becquet, F ^a,b   Courtois, Y ^a   Goureau, O ^a  

^a BICHAT HOSPITAL   (France)

^b INSERM   (France)

Author keywords

Glaucoma; Inflammation; NADPH diaphorase; Nitric oxide; Nitric oxide synthase; Nitric oxide synthase inhibitors; Retina

Indexed keywords

NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE DEHYDROGENASE;

ARTICLE; BLOOD VESSEL TONE; ENZYME POLYMORPHISM; GLAUCOMA; HOMEOSTASIS; INFLAMMATION; PHOTOTRANSDUCTION; PIGMENT EPITHELIUM; PRIORITY JOURNAL; RETINA DEGENERATION; RETINA ISCHEMIA; RETINITIS;

EID: 0030861099     PISSN: 00396257     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0039-6257(97)84043-X     Document Type: Article

References (110)

1. Ahmad I, Leinders-Zufall T, Kocsis JD, et al: Retinal ganglion cells express a cGMP-gate cation conductance activatable by nitric oxide donors. Neuron 12:155-165, 1994
2. Allen JB, McGahan MC, Ferrell JB, et al: Nitric oxide synthase inhibitors exert differential time-dependent effects on LPS-induced uveitis. Exp Eye Res 62:21-28, 1996
3. Bailard P, Bollack J: De l'action comparé de certaines substances médicamenteuses sur la tension intraoculaire et sur la pression artérielle. Ann Ocul 158:641-654, 1921
4. Baldridge WH, Jamieson MS, Ball AK: Role of nitric oxide in the control of horizontal cell receptive-field size. Invest Ophthalmol Vis Sci 34:1382, 1993
5. Barany EH: The immediate effect on outflow resistance of intravenous pilocarpine in the vervet monkey, C ethi OP. Invest Ophthalmol 6:373-380, 1967
6. Becker B: Topical 8-bromo-cyclic GMP lowers intraocular pressure in rabbits. Invest Ophthalmol Vis Sci 31:1647-1649, 1990
7. Beckman JS, Crow JP: Pathological implications of nitric oxide, superoxide and peroxynitrite formation. Biochem Soc Trans 21:330-334, 1993
8. Becquet F, Courtois Y, Goureau O: Nitric oxide decreases in vitro phagocytosis of photoreceptor outer segments by bovine retinal pigmented epithelial cells. J Cell Physiol 159:259-262, 1994
9. Bredt DS, Snyder SH: Nitric oxide: a physiologic messenger molecule. Ann Rev Biochem 63:175-195, 1994
10. Brodehl D, Steinbach PD: Wie wirkz nitroglycerin auf den intraocularen druck. Klin Monatsbl Augenheilkd 166:784-788, 1975
11. Chakravarthy U, Stitt AW, McNally J et al: Nitric oxide synthase activity and expression in retinal capillary endothelial cells and pericytes. Curr Eye Res 14:285-294, 1995
12. Cristini G, Pagliarani N: Esplorazione clinica delta circolazione uveale anche a scopo prognostico, nel glaucoma primario. Arch Oftalmol B Air 28:145-149, 1953
13. Davidson PC, Sterneberg P Jr: Potential retinal phototoxicity. Am J Ophthalmol 116:497-501, 1993
14. Dawson DA: Nitric oxide and focal ischemia: multiplicity of actions and diverse outcome. Cerebrovasc Brain Metab Rev 6:299-324, 1994
15. Digheiro P, Reux I, Hauw JJ, et al: Expression of inducible nitric oxide synthase in cytomegalovirus-infected glial cells of retinas from AIDS patients. Neurosci Lett 166:31-34, 1994
16. Donati G, Pournaras CJ, Munoz J, et al: Nitric oxide controls arteriolar tone in the retina of the miniature pig. Invest Ophthalmol Vis Sci 36:2228-2238, 1995
17. Drance SM, Douglas GR, Wijsman K, et al: Response of blood flow to warm and cold in normal and low-tension glaucoma patients. Am J Ophthalmol 105:35-39, 1988
18. Ehret-Hilberer S, Nullans G, Aunis D, Virmaux N: Mono ADP-ribosylation of transducin catalyzed by rod outer segment extract. FEBS Lett 309:394-398, 1992
19. Erickson-Lamy K, Nathanson J: The effects of endothelin, atrial natriuretic factor and nitroglycerine on outflow facility in the primate eye, in Lutjen-Drecoll E (ed): Basic Apsects of Glaucoma Research III. Mainz, Schattauer Verlag, 1993, pp 275-285
20. Fleisher LN, Ferrel JB, McGahan MC: Ocular inflammatory effects of intravitreally injected tumor necrosis factor-α and endotoxin. Inflammation 14:325-335, 1990
21. Flugel C, Barany EH, Lütjen-Drecoll E: Histochemical differences within the ciliary muscle and its function in accommodation. Exp Eye Res 50:219-226, 1990
22. Förstermann U, Kleinert H: Nitric oxide synthase: expression and expressional control of the three isoforms. Naunyn-Schmiedeberg's Arch Pharmacol 352:351-364, 1995
23. Gehlbach P, Purple RL: Enhancement of retinal recovery by conjugated deferoxamine after ischemia-reperfusion. Invest Ophthalmol Vis Sci 35:669-676, 1994
24. Geyer O, Almog J, Lupu-Meiri M, et al: Nitric oxide synthase inhibitors protect rat retina against ischemic injury. FEBS Lett 374:399-402, 1995
25. Goureau O, Lepoivre M, Courtois Y: Lipopolysaccharide and cytokines induce a macrophage-type of nitric oxide synthase in bovine retinal pigmented epithelial cells. Biochem Biophys Res Comm 186:854-859, 1992
26. Goureau O, Lepoivre M, Mascarelli F, Courtois Y: Nitric oxide synthase activity in bovine retina, in Rigaud JL and INSERM (eds): Structures and Functions of Retinal Proteins, Vol. 221. London, J Libbey Eurotext Ltd, 1992, pp 395-398
27. Goureau O, Lepoivre M, Becquet F, Courtois Y: Differential regulation of inducible nitric oxide synthase by basic fibroblast growth factors and transforming growth factor β in bovine retinal pigmented epithelial cells: inverse correlation with cellular proliferation. Proct Natl Acad Sci USA 90:4276-4280, 1993
28. Goureau O, Jeanny JC, Becquet F, et al: Protection against light-induced retinal degeneration by an inhibitor of nitric oxide synthase inhibitor. Neuroreport 5:233-236, 1993
29. Goureau O, Hicks D, Courtois Y: Human retinal pigmented epithelial cells produce nitric oxide in response to cytokines. Biochem Biophys Res Comm 198:120-126, 1994
30. Goureau O, Hicks D, Courtois Y, de Kozak Y: Induction and regulation of nitric oxide synthase in retinal Müller glial cells. J Neurochem 63:310-7, 1994
31. Goureau O, Becquet F, Courtois Y: Potential involvement in retinal degeneration and its control by growth factors and cytokines, in Anderson RF, Hollyfield RG, La Vail MM (eds): Degenerative Diseases of the Retina. New York, Plenum Press, 1995, pp 61-68
32. Goureau O, Bellot J, Thillaye B, et al: Increased nitric oxide production in endotoxin-induced uveitis: reduction of uveitis by an inhibitor of nitric oxide synthase. J Immunol 154:6518-6523, 1995
33. Goureau O, Faure V, Courtois Y: Fibroblast growth factors decrease inducible nitric oxide synthase mRNA accumulation in bovine retinal pigmented epithelial cells. Eur J Biochem 230:1046-1052, 1995
34. Grant WM: Physiological and pharmacological influences upon intraocular pressure. Pharmacological Rev 7:143-182, 1955
35. Haefliger IO, Flammer J, Lüscher TF: Nitric oxide and endothelin-1 are important regulators of human ophthalmic arteries. Invest Ophthalmol Vis Sci 33:2340-2343, 1992
36. Haefliger IO, Meyer P, Flammer J, Lüscher TF: The vascular endothelium as a regulator of the ocular circulation: a new concept in ophthalmology. Surv Ophthalmol 39:123-132, 1994
37. Henry Y, Lepoivre M, Drapier JC, et al: EPR characterization of molecular targets for nitric oxide in mammalian cells and organelles. FASEB J 7:1124-1134, 1993
38. Hicks D, Bugra K, Fauchcux B, et al: Fibroblast growth factors in the retina. Prog Ret Res 11:333-374, 1991
39. Hoeckzema R, Verhagen C, Van Haren M, Kiljstra A: Endotoxin-induced uveitis in the rat. Invest Ophthalmol Vis Sci 33:532-539, 1992
40. Huxlin KR, Bennett MR: NADPH diaphorase expression in the rat retina after axotomy - a supportive role for nitric oxide. Eur J Neurosci 7:2226-2239, 1995
41. Ischiropoulos H, Zhu L, Chen J et al: Peroxynitrite-mediated tyrosine nitration catalysed by superoxide dismutase. Arch Biochem Biophys 298:431-437, 1992
42. Jacquemin E, De Kozak Y, Thillaye B, et al: Expression of inducible nitric oxide synthase in the eye from endotoxin-induced uveitis rats. Invest Ophthalmol Vis Sci 37:1187-1196, 1996
43. Kaufman PL, Gabelt BT: Cholinergic mechanisms and aqueous humor dynamics, in Drance S, Neufeld A, Van Buskirk E (eds): Applied Pharmacology of the Glaucomas. Baltimore, Williams and Wilkins, 1992, pp 64-92
44. Kerwin JF Jr, Lancaster JR Jr, Feldman PL: Nitric oxide: a new paradigm for second messengers. J Med Chem 38:4343-4362, 1995
45. Knowles RG, Moncada S: Nitric oxide synthases in mammals. Biochem J 298:249-258, 1994
46. Koch K, Lambrecht H, Haberecht M, et al: Functional coupling of a calcium/calmodulin-dependent nitric oxide synthase and a soluble guanyl cyclase in vertebrate photoreceptor cells. EMBO J 13:3312-3320, 1994
47. Koistinaho J, Sagar SM: NADPH-diaphorase reactive neurones in the retina. Prog Ret Eye Res 15:69-87, 1995
48. Kollner H: Uber den Augendrück beim Glaucoma simplex und seine Beziehungen zum Kreislauf. Arch Augenheilkd 83:135-167, 1918
49. Korenfeld MS, Becker B: Atrial natriuretic peptides: effects on intraocular pressure, cGMP and aqueous flow. Invest Ophthalmol Vis Sci:30:2385-2392, 1989
50. Kröncke KD, Fehsel K, Kolb-Bachofen V: Inducible nitric oxide synthase and its product nitric oxide, a small molecule with complex biological activities. Biol Chem Hoppe-Seyler 376:327-343, 1995
51. Kurenny DE, Moroz LL, Turner RW, et al: Modulation of ion channels in rod photoreceptors by nitric oxide. Neuron 13:315-324, 1994
52. Lieppe BA, Stone C, Koistinaho J, Copenhagen DR: Nitric oxide synthase in Müller cells and neurons of salamander and fish retina. J Neurosci 14:7641-7654, 1994
53. Lipton SA, Choi YB, Pan ZH, et al: A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso-compounds. Nature 364:626-632, 1993
54. Liversidge J, Grabowski P, Ralston S, et al: Rat retinal pigment epithelial cells express an inducible form of nitric oxide synthase and produce nitric oxide in response to inflammatory cytokines and activated T cells. Immunology 83:404-409, 1994
55. McMahon DG: Modulation of zebrafish horizontal cell electrical synapses by nitroprusside and cGMP. Invest Ophthalmol Vis Sci 35:1821, 1994
56. Malecaze F, Mathis A, Arne JL, et al: Localization of acidic fibroblast growth factor in proliferative vitreoretinopathy membranes. Curr Eye Res 10:719-729, 1991
57. G-nitro L-arginine. Invest Ophthalmol Vis Sci 35:3673-3681, 1994
58. Marietta MA: Nitric oxide synthase structure and mechanism. J Biol Chem 268:12231-12234, 1993
59. Marietta MA: Approaches toward selective inhibition of nitric oxide synthase. J Med Chem 37:1899-1907, 1994
60. Meijer F, Van Delft JL, Garrelds IM, et al: Nitric oxide plays a role as a mediator of conjunctival edema in experimental allergic conjunctivitis. Exp Eye Res 62:359-365, 1996
61. Mills SL, Massey SC: L-arginine uncouples A-type horizontal cells in rabbit retinal. Invest Ophthalmol Vis Sci 34:1382, 1993
62. Mittag TW, Tormay A, Ortega M, Severin C: Atrial natriuretic peptide (ANP), guanylate cyclase, and intraocular pressure. Curr Eye Res 6:1189-1196, 1987
63. Miyachi EI, Murakami M, Nakaki T: Arginine blocks gap junctions between retinal horizontal cells. Neuroreport 1:107-110, 1990
64. Moncada S, Higgs EA: Molecular mechanisms and therapeutic strategies related to nitric oxide. FASEB J 9:1319-1330, 1995
65. Nathan CF: Nitric oxide as a secretory product of mammalian cells. FASEB J 6:3051-3064, 1992
66. Nathan CF, Xie Q: Nitric oxide synthases: roles, tolls, and controls. Cell 78:915-918, 1994
67. Nathanson JA: Atriopeptin-activated guanylate cyclase in the anterior segment. Identification, localization and effects of atriopeptins on IOP. Invest Ophthalmol Vis Sci 28, 1357-1364, 1987
68. Nathanson JA: Direct application of a guanylate cyclase activator lowers intraocular pressure. Eur J Pharmacol 147:155-156, 1988
69. Nathanson JA: Nitrovasodilatators as a new class of ocular hypotensive agents. J Pharmacol Exp Ther 260:956-965, 1992
70. Nathanson JA, Bartels S, Krug J: Ocular actions of atrial natriuretic peptides and guanylate cyclase activators, in Drance S, Neufeld A, Van Buskirk E (eds): Applied Pharmacology of the Glaucomas. Baltimore, Williams and Wilkins, 1992, pp 158-174
71. Nathanson JA, McKee M: Identification of an extensive system of nitric oxide-producing cells in the ciliary muscle and outflow pathway of the human eye. Invest Ophthalmol Vis Sci 36:1765-1773, 1995
72. Nathanson JA, McKee M: Alterations of ocular nitric oxide synthase in human glaucoma. Invest Ophthalmol Vis Sci 36:1774-1784, 1995
73. Neufeld AH: Influences of cyclic nucleotides on outflow facility in the vervet monkey. Exp Eye Res 27:387-397, 1978
74. Noll GN, Billek M, Pietruck C, Schmidt KF: Inhibition of nitric synthase alters light responses and dark voltage of amphibian photoreceptors. Neuropharmacology 33:1407-1412, 1994
75. Nussler AK, Billiar TR: Inflammation, immunoregulation, and inducible nitric oxide synthase. J Leuko Biol 54:171-178, 1993
76. Ophir A, Berenshtein E, Kitrossky N, et al: Hydroxyl radical generation in the cat retina during reperfusion following ischemia. Exp Eye Res 57:351-357, 1993
77. Organisciak DT, Darrow RM, Bicknell IR, et al: Protection against retinal light damage by natural and synthetic antioxydants, in Anderson RE, Hollyfield JG, La Vail MM (eds): Retinal Degenerations. Boca Raton, CRC Press, 1991, pp 189-201
78. Osborne NN, Barnett NL, Herrera AJ: NADPH diaphorase localization and nitric oxide synthetase activity in the retina and anterior uvea of the rabbit eye. Brain Res 610:194-198, 1993
79. Ostwald P, Goldstein IR, Pachnanda A, Roth S: Effect of nitric oxide synthase inhibition on blood flow after retinal ischemia in cats. Invest Ophthalmol Vis Sci 36:2396-2403, 1995
80. Park C, Pardhasaradhi K, Gianotti C, et al: Human retina expresses both constitutive and inducible isoforms of nitric oxide synthase mRNA. Biochem Biophys Res Comm 205:85-91, 1994
81. Parks DJ, Cheung MK, Chan CC, Roberge FG: The role of nitric oxide in uveitis. Arch Ophthalmol 112:544-546, 1994
82. Perez MTR, Larsson B, Alm P, et al: Localization of neuronal nitric oxide synthase-immunoreactivity in rat and rabbit retinas. Brain Res 104:207-217, 1995
83. Pozdnyakov N, Lloyd A, Reddy VN, Sitaramayva A: Nitric oxide-regulated endogenous ADP-ribosylation of rod outer segment proteins. Biochem Biophys Res Commun 192:610-615, 1993
84. Radi R, Beckman JS, Bush M, Freeman BA: Peroxynitrite oxidation of sulfhydryls. The cytotoxic potential of superoxide and nitric oxide. J Biol Chem 266:4244-4250, 1991
85. Radons J, Heller B, Bürkle A, et al: Nitric oxide toxicity in islet cells involves poly(ADP-ribose) polymerase activation and concomitant NAD+ depletion. Biochem Biophys Res Commun 199:1270-1277, 1994
86. Rohen JW: The evolution of the primate eye in relation to the problem of glaucoma, in Lüjen-Drecoll E (ed): Basic Aspects of Glaucoma Research. Stuttgart, FK Schattauer Verlag, 1982, pp 3-33
87. Rohen JW, Lutjen-Drecoll E: Morphology of aqueous outflow pathways in normal and glaucomatous eyes, in Ritch R, Shield M, Krupin T (ed): The Glaucomas. Philadelphia, CV Mosby, 1989, pp 41-74
88. Rosenbaum JT, MacDevitt HO, Guss RB, Egbert PR: Endotoxin-induced uveitis in rats as a model for human disease. Nature 286:611-613, 1980
89. Ruiz-Moreno JM, Thillaye B, de Kozak Y: Retino-choroidal changes in endotoxin-induced uveitis. Ophthalmic Res 24:162-168, 1992
90. Schmidt HHHW, Lohmann SM, Walter U: The nitric oxide and cGMP signal transduction system: regulation and mechanism of action. Biochim Biophys Acta 1178:153-175, 1993
91. Schmidt KF, Null GN, Yamamoto Y: Sodium nitroprusside alters dark voltage and light responses in isolated retinal rods during whole-cell recording. Vis Neurosci 9:205-209, 1992
92. Schuman J, Erickson K, Nathanson JA: Nitrovasodilator effects on intraocular pressure and outflow facility in monkeys. Exp Eye Res 58:99-105, 1994
93. Shiells R, Falk G: Retinal on-bipolar cells contain a nitric oxide-sensitive guanylate cyclase. Neuroreport 3:845-848, 1992
94. Sparrow JR, Nathan CF, Vodovotz Y: Cytokine regulation of nitric oxide synthase in mouse retinal pigment epithelial cells in culture. Exp Eye Res 59:129-139, 1994
95. Stamler JS, Simon DI, Osborne JA, et al: S-nitrosylation of proteins with nitric oxide: synthesis and characterization of biologically active compounds. Proc Natl Acad Sci USA 89:444-448, 1992
96. Stamler JS, Singel JS, Loscalzo J: Biochemistry of nitric oxide and its redox-activated forms. Science 258:1898-1902, 1992
97. Stamler JS: Redox signaling: nitrosylation and related target interactions of nitric oxide. Cell 78:931-936, 1994
98. Tilton RG, Chang K, Corbett JA, et al: Endotoxin-induced uveitis in the rat is attenuated by inhibition of nitric oxide production. Invest Ophthalmol Vis Sci 35:3278-3288, 1994
99. Toda N, Kitamura Y, Okamura T: Role of nitroxidergic nerve in dog retinal arterioles in vivo and arteries in vitro. Am J Physiol 35:H1985-H1992, 1994
100. Tsuyama Y, Null GN, Schmidt KF: L-arginine and nicotinamide adenine dinucleotide phosphate alter dark voltage and accelerate light response recovery in isolated retinal rods of the frog (Rana temporaria). Neurosci Lett 149:95-98, 1993
101. Vallance P, Moncada S: Role of endogenous nitric oxide in septic shock. New Horizons 1:77-86, 1993
102. Venturini CM, Knowles RG, Palmer RMJ, Moncada S: Synthesis of nitric oxide in the bovine retina. Biochem Biophys Res Comm 180:920-925, 1991
103. Verracchia C, Boulu RG, Plotkine M: Neuroprotective and deleterious effects of nitric oxide on focal cerebral ischemia-induced neuron death. Adv Neuroimmunol 5:359-375, 1995
104. Whitworth CG, Grant WM: Use of nitrate and nitrite vasodilatators in glaucomatous patients. Arch Ophthalmol 71:492-496, 1964
105. Widerholt M, Sturn A, Lepple-Wienhues A: Relaxation of trabecular meshwork and ciliary muscle by release of nitric oxide. Invest Ophthalmol Vis Sci 35:1515-1520, 1994
106. Yamamoto R, Bredt DS, Snyder SH, Stone RA: The localization of nitric oxide synthase in the eye and related cranial ganglia. Neurosci 54:189-200, 1993
107. Yoshida A, Pozdnyakov N, Dang E, et al: Nitric oxide synthesis in retinal photoreceptor cells. Vis Neurosci 12:493-500, 1995
108. Zahn K: The effect of nitroglycerin on the retinal circulation. Cesk Oftalmol 13:146-149, 1957
109. Zhang J, Dawson VL, Dawson TM, Snyder SH: Nitric oxide activity of poly(ADP-ribose) synthetase in neurotoxicity. Science 263:687-689, 1994
110. Zoche M, Koch KW: Purified retinal nitric oxide synthase enhances ADP-ribosylation of rod outer segments proteins. FEBS Lett 357:178-182, 1995